T. Rowe Price Associates »

Soleno Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $66M 1.3M 50.49
2024-06-30 $20M 478k 40.83
2024-03-31 $6.5M 153k 42.81

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Soleno Therapeutics

Carlyle
Henderson Group
Nantahala Capital Management
Perceptive Advisors
BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Commodore Capital
State Street Corporation
Alyeska Investment Group
Sofinnova Ventures
Frazier Life Sciences Management
Vestal Point Capital
Holocene Advisors

View all funds holding Soleno Therapeutics